UMRX Shares Outstanding History
Below is a table of the UMRX shares outstanding history going back to 3/29/2018:

Date UMRX Shares Outstanding

Also see: UMRX Market Cap History
UMRX Historical Shares Outstanding:
+11.51% CAGR
UMRX Historical Shares Outstanding: +11.51% CAGR

Mouse over chart for data details
3/29/2018 ...8/7/2020
Unum Therapeutics is a biopharmaceutical company focused on developing curative cell therapies for solid tumors. Co.'s proprietary technology includes its Bolt-On Chimeric Receptor platform, designed to discover bolt-on transgenes to improve the functionality of engineered T cells and overcome resistance of the solid tumor microenvironment to T cell attack. Co. has also developed product candidates using its proprietary technology, Antibody-Coupled T cell Receptor, an autologous engineered T-cell investigational therapy that is designed to combine the cell-killing ability of T cells and the tumor-targeting ability of co-administered antibodies to exert antitumor immune responses. We show 12 historical shares outstanding datapoints in our coverage of UMRX's shares outstanding history.

Understanding the changing numbers of UMRX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like UMRX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching UMRX by allowing them to research UMRX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree UMRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Unum Therapeutics (UMRX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

UNCY Shares Outstanding History
USPH Shares Outstanding History
UTHR Shares Outstanding History
UTMD Shares Outstanding History
UTRS Shares Outstanding History
VAPO Shares Outstanding History
VAR Shares Outstanding History
VAXX Shares Outstanding History
VBIV Shares Outstanding History
VCEL Shares Outstanding History
More Healthcare companies »


UMRX Shares Outstanding History | | Copyright © 2017 - 2023, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.